Try Now
Try Now

5 Ways to Optimize Trial Designs

July 28, 2020

5 Ways to Optimize Trial Designs

1 - Better Design

  • Every design choice will have some effect on the required sample size
  • Good designs are efficient and thus reduce sample size
  • Design decisions include - randomization level (Subject level Vs Cluster level etc)
    • Crossover vs parallel (Crossover design can be more efficient if chronic disease)
    • Choice of endpoint - closer endpoint is to actual measure the better 
    • Some unneeded simplifications increase costs - dictomisation, treating TTE as binary, recurrent events as TTE
    • Covariate Selection should be part of the study design and protocol

2 - Real World Evidence

  • Using RWE can help researchers determine a viable study length and frequency of study events when designing their trial
  • Enable researchers to assess site feasibility from previous data from site-specific clinical trials that were successful
  • Create Synthetic Control Arms and therefore allow all recruited patients to be in the active arm
  • Trial planners can assess and model protocols to reduce potential patient issues which lead to dropout, prior to commencing the trial

3 - Bayesian Assurance

  • Frequentists can gain greater insight and ideally make better decisions to complement their frequentist trial with Bayesian assurance
  • Take advantage of prior information and expert opinion
  • Bayesian (Power) Assurance - “True Probability of Success” very useful at financial & scientific Review boards.
  • Can help you formalize your sample size sensitivity analysis

4 - Adaptive Trials 

  • Adaptive Designs can lead to more efficient clinical trials
  • Group Sequential Design & Sample Size Re-estimation facilitates interim analyses where you can either stop for benefit or futility or increase your sample size if the effect size is promising
  • Other Adaptive areas include enrichment, seamless trials and dose finding
  • Adaptive Trials can reduce costs and risks and result in earlier decisions
  • Patients may also favour enrolling in adaptive trials because of the increased probability they will receive more effective treatment

5 - Master Protocols

  • The FDA guidelines describe two types of master protocol designs. 
    • The basket trial design tests a single oncology drug in various populations 
    • The umbrella trial design is used to evaluate multiple investigational oncology drugs in a single disease population
    • Ability to “bundle” treatments and garner economies of scale (reduce paperwork and duplication of activities)
    • From the perspective of the sites there can be a great reduction in overhead resulting in significant cost savings
    • Evaluate safety and efficacy of treatments in parallel instead of sequentially
    • Reduce patient exposure to control arms

Suggested Reading

A guest blog post from Quanticate-Logo.

An Introduction to Adaptive Clinical Trial Designs - Guest Blog by Quanticate

(Updated July 28th 2020)

You May Also Like

These Stories on Guide to Sample Size

Subscribe by Email

No Comments Yet

Let us know what you think